Nitrogen-containing bisphosphonates are potent inhibitors of osteoclastic bone resorption.
With their individually proven efficacy to significantly reduce the incidence of vertebral and/or …

AIM: To evaluate the computed tomography (CT) and magnetic resonance imaging (MRI)
findings of biphosphonate therapy-associated changes of the mandible and maxilla …

Bisphosphonates (BPs) are widely prescribed drugs used to treat osteoporosis, commonly
arising in postmenopausal women and in chronic glucocorticoid use. Their mechanism of …

PURPOSE: Atypical femur fractures represent a potential complication of chronic oral
bisphosphonate therapy in women with osteoporosis, but the risk of atypical femur fractures …

The efficacy of 3 years of annual intravenous administration of zoledronic acid (ZOL) in
reducing vertebral and nonvertebral fractures in postmenopausal osteoporosis has been …

The availability of a once-a-year zoledronic acid infusion heralds a new era in the
management of osteoporosis. It virtually eliminates the problem of poor compliance with …

An ageing population and greater number of hip and knee replacements performed have
led to an increasing number of patients with ipsilateral hip and knee replacements in situ …

Abstract The World Health Organization predicts that people aged older than 65 years will
comprise 20% of the world's population by 2030. One of the most commonly prescribed …

Objective To analyze the clinical efficacy of zoledronic acid combined with pulsed
osteoporosis of electromagnetic therapy on postmenopausal osteoporosis. Methods Sixty …